Insider filing · PHVS
Elisabeth Bjork
Director
profile →
Pharvaris N.V.
PHVS · Healthcare · 30 filings in 24 months
ticker →
Elisabeth Bjork sold $2.0M of Pharvaris (PHVS)
Executed Sep 17, disclosed Sep 21, 4 days later.
Value, as filed
$2.0M
52,500 sh × $37.89
Executed
Sep 17
the trade date, as filed
Disclosed
Sep 21
4 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
EBElisabeth Bjork (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Pharvaris N.V. (PHVS). The largest single filing was $2.0M of PHVS (52,500 sh × $37.89, as filed), executed Sep 17.
The name
PHVSHealthcare · Pharvaris N.V., a late-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases wit…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Elisabeth Bjork in PHVS
PHVSSALE
Pharvaris N.V.
$293K10,000 sh × $29.32
Exec May 20
Filed May 22 · 5:30 PM ET